Cargando…
Medication burden in the first 5 years following diagnosis of type 2 diabetes: findings from the ADDITION-UK trial cohort
INTRODUCTION: Individuals with screen-detected diabetes are likely to receive intensified pharmacotherapy to improve glycaemic control and general cardiometabolic health. Individuals are often asymptomatic, and little is known about the degree to which polypharmacy is present both before, and after...
Autores principales: | Black, James A, Simmons, Rebecca K, Boothby, Clare E, Davies, Melanie J, Webb, David, Khunti, Kamlesh, Long, Gráinne H, Griffin, Simon J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593027/ https://www.ncbi.nlm.nih.gov/pubmed/26448867 http://dx.doi.org/10.1136/bmjdrc-2014-000075 |
Ejemplares similares
-
Early Detection and Treatment of Type 2 Diabetes Reduce Cardiovascular Morbidity and Mortality: A Simulation of the Results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe)
por: Herman, William H., et al.
Publicado: (2015) -
How good are GPs at adhering to a pragmatic trial protocol in primary care? Results from the ADDITION-Cambridge cluster-randomised pragmatic trial
por: Laxy, Michael, et al.
Publicado: (2018) -
Estimating the economic burden of cardiovascular events in patients receiving lipid-modifying therapy in the UK
por: Danese, Mark D, et al.
Publicado: (2016) -
Association between pre-diabetes and microvascular and macrovascular disease in newly diagnosed type 2 diabetes
por: Palladino, Raffaele, et al.
Publicado: (2020) -
Management of lipid-lowering therapy in patients with cardiovascular events in the UK: a retrospective cohort study
por: Danese, Mark D, et al.
Publicado: (2017)